SUSAN KANG: Open Payments
NPI 1760626030 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 5 payments from 4 companies in 2025. Trend: 2023 $554 · 2024 $393 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $286 |
| Novo Nordisk Inc | 1 | $120 |
| DePuy Synthes Sales Inc. | 1 | $40 |
| Gilead Sciences, Inc. | 1 | $27 |
Products named: REZDIFFRA, Wegovy, CEREPAK UNIFORM.
Industry payments across CA — which companies pay providers there.
